FDA Adverse Event Injury Summary report: N

KYPHON INFLATABLE BONE TAMP

MDR report key: 2162790 · Received July 15, 2011

Report

Report Number
2953769-2011-00086
Event Type
Injury
Date Received
July 15, 2011
Date of Event
April 19, 2011
Report Date
July 1, 2011
Manufacturer
MEDTRONIC SPINE LLC.
Product Code
HRX
PMA / PMN Number
K981251
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(6). REPORT SOURCE: ARTICLE TITLED "UNILATERAL EXTRAPEDICULAR VERTEBROPLASTY AND KYPHOPLASTY IN LUMBAR COMPRESSION FRACTURES : TECHNIQ UE, ANATOMY AND PRELIMINARY RESULTS", BY SUNG-MIN CHO, M.D., YONG-SUK NAM, PH.D., BYUNG-MOON CHO, M.D., PH.D., SANG-YOUL LEE, M.D., PH.D., SAE-MOON OH, M.D., PH.D., MOON-KYU KIM, M.D., PH.D. EVAL METHOD: FOLLOW-UP WITH COMPANY REPRESENTATIVE.

Description of Event or Problem · 1

IN AN ARTICLE TITLED "UNILATERAL EXTRAPEDICULAR VERTEBROPLASTY AND KYPHOPLASTY IN LUMBAR COMPRESSION FRACTURES : TECHNIQUE, ANATOMY AND PRELIMINARY RESULTS", A RETROSPECTIVE STUDY WAS CONDUCTED ON 55 CONSECUTIVE PATIENTS WHO UNDERWENT PERCUTANEOUS EXTRAPEDICULAR UNILATERAL KYPHOPLASTY OR VERTEBROPLASTY FOR PAINFUL OSTEOPOROTIC VERTEBRAL COMPRESSION FRACTURES AT THE 74 LUMBAR LEVELS BETWEEN (B)(6) 2006 AND (B)(6) 2009. THE FOLLOWING EVENTS WERE REPORTED. -EPIDURAL CEMENT LEAKAGE INTO NEURAL CANAL WAS NOTED IN 3 KYPHOPLASTY CASES (4.1%) BY POSTOPERATIVE PLAIN RADIOGRAPHY, BUT THERE WERE NO NEUROLOGICAL DEFICITS. -ONE CASE (1.4%) OF RETROPERITONEAL HEMORRHAGE OCCURRED AFTER KYPHOPLASTY DUE TO KIDNEY INJURY. NO FURTHER INFORMATION WAS REPORTED. NOTE: THIS STUDY WAS APPROVED BY THE INSTITUTIONAL REVIEW BOARD OF (B)(6) UNIVERSITY COLLEGE OF MEDICINE IN (B)(6). KYPHOPLASTY PRODUCTS ARE NOT APPROVED FOR DISTRIBUTION IN (B)(6). CEMENT USED IN THIS STUDY WAS (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 KYPHON INFLATABLE BONE TAMP ARTHROSCOPE HRX MEDTRONIC SPINE LLC. UNK

Patients

Seq Age Sex Outcome Treatment
1 00072 YR Other